We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+1.95%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$97.6B
AUM Growth
-$1.7B
Cap. Flow
-$3.16B
Cap. Flow %
-3.24%
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$382M
2
HSP
HOSPIRA INC
HSP
+$235M
3
MRK icon
Merck
MRK
+$227M
4
AGN
Allergan Inc
AGN
+$199M
5
AXP icon
American Express
AXP
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 19.47%
2 Financials 16.8%
3 Industrials 9.81%
4 Technology 8.84%
5 Energy 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEE icon
2951
Ameren
AEE
$31.1B
$114K ﹤0.01%
2,694
-22,300
-89% -$970K
CLFD icon
2952
Clearfield
CLFD
$425M
$114K ﹤0.01%
7,690
+833
+12% +$11.1K
FNLC icon
2953
First Bancorp
FNLC
$400M
$114K ﹤0.01%
6,550
+583
+10% +$9.84K
OCUL icon
2954
Ocular Therapeutix
OCUL
$1.85B
$114K ﹤0.01%
2,709
+568
+27% +$18.7K
FFNW
2955
DELISTED
First Financial Northwest, Inc
FFNW
$114K ﹤0.01%
9,222
+1,293
+16% +$15.7K
HWCC
2956
DELISTED
Houston Wire & Cable Company
HWCC
$114K ﹤0.01%
11,686
+1,723
+17% +$18.4K
NWY
2957
DELISTED
New York & Co Inc
NWY
$114K ﹤0.01%
45,465
+1,961
+5% +$4.55K
DMRC icon
2958
Digimarc Corp
DMRC
$145M
$113K ﹤0.01%
5,148
+1,077
+26% +$27.5K
RVNC
2959
DELISTED
Revance Therapeutics, Inc.
RVNC
$113K ﹤0.01%
5,473
+561
+11% +$9.69K
VCRA
2960
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$113K ﹤0.01%
11,411
+2,594
+29% +$25.6K
LGIH icon
2961
LGI Homes
LGIH
$1.43B
$112K ﹤0.01%
6,751
+1,001
+17% +$14.1K
LYTS icon
2962
LSI Industries
LYTS
$880M
$112K ﹤0.01%
13,707
+1,564
+13% +$11.5K
OKE icon
2963
Oneok
OKE
$55.9B
$112K ﹤0.01%
2,312
-2,212
-49% -$101K
ONDK
2964
DELISTED
On Deck Capital, Inc.
ONDK
$112K ﹤0.01%
5,244
-292,956
-98% -$5.53M
GST
2965
DELISTED
Gastar Exploration Inc.
GST
$112K ﹤0.01%
42,672
+5,986
+16% +$15.5K
KCLI
2966
DELISTED
KANSAS CITY LIFE INS CO NEW (MO)
KCLI
$112K ﹤0.01%
2,448
+342
+16% +$15.9K
REXX
2967
DELISTED
Rex Energy Corporation
REXX
$112K ﹤0.01%
3,009
+321
+12% +$13.2K
GEN
2968
DELISTED
Genesis Healthcare, Inc.
GEN
$111K ﹤0.01%
+15,644
New +$118K
HNH
2969
DELISTED
Handy & Harman Holdings Ltd.
HNH
$111K ﹤0.01%
2,701
+372
+16% +$16.3K
FRPT icon
2970
Freshpet
FRPT
$3.01B
$110K ﹤0.01%
5,636
-13,800
-71% -$231K
CUNB
2971
DELISTED
CU Bancorp
CUNB
$110K ﹤0.01%
4,818
+1,040
+28% +$22K
SZMK
2972
DELISTED
SIZMEK INC COM STK (DE)
SZMK
$110K ﹤0.01%
15,179
-6,046
-28% -$42.4K
DEA
2973
Easterly Government Properties
DEA
$1.17B
$109K ﹤0.01%
+2,708
New +$108K
EHTH icon
2974
eHealth
EHTH
$43.2M
$109K ﹤0.01%
11,617
+1,772
+18% +$21.2K
QTWO icon
2975
Q2 Holdings
QTWO
$3.71B
$109K ﹤0.01%
5,133
+1,209
+31% +$23.8K

Similar funds

BlackRock Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors withdrew a net $3.16B in Q1 2015, closing 154 positions and reducing 812 holdings. Its most notable exit was Allergan Inc, an estimated $199M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, BlackRock Advisors opened a new position in Mobileye N.V. worth $252M.

  • BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
  • BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
  • BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
  • BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
  • BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
  • BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.

Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.